GlassScriptPhysician profile
Harvey B Lefton
NPI 1346204872
$4,498.25
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,930 · 2020: $680 · 2021: $1,125 · 2022: $763.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,631.17 | 2019-2022 | |
| Abbvie INC. | $760.05 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $534.74 | 2019-2022 | |
| Janssen Biotech, INC. | $533.57 | 2019-2022 | |
| Gilead Sciences, INC. | $245.08 | 2019-2022 | |
| Ucb, INC. | $125.01 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $99.07 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $74.71 | 2019-2022 | |
| Redhill Biopharma INC. | $65.11 | 2020-2022 | |
| Allergan, INC. | $64.16 | 2019-2020 | |
| Pfizer INC. | $56.02 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $55.26 | 2020-2022 | |
| Daiichi Sankyo INC. | $48.20 | 2021 | |
| Evoke Pharma, INC. | $41.57 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $38.30 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $36.26 | 2019 | |
| Celgene Corporation | $34.35 | 2021-2022 | |
| Ardelyx, INC. | $20.53 | 2022 | |
| Shire North American Group INC | $17.76 | 2019 | |
| Dynavax Technologies Corporation | $17.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Lefton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.